Articles:
Publications:

Jul. 15, 2026

Congo Launches Trial for New Ebola Treatment

Congo Launches Trial for New Ebola Treatment

Scientists in the Democratic Republic of Congo have begun enrolling participants in a clinical trial that will test the effectiveness of the experimental antiviral obeldesivir as a post-exposure treatment for the Bundibugyo strain of the Ebola... Read more.

More on this topic

Brussels Morning 9 minutes ago
Turn on Transparency.
Ebola Patients Flee After Attack on Congo Hospital Disrupts Outbreak Response
Owner: Vera Goeminne through The Brussels Morning Newspaper Ltd More info
Channels TV 13 minutes ago
Turn on Transparency.
Ebola Spreading In DRC ‘Faster Than Any Previous Outbreak,’ WHO Chief Warns
Owner: John & Sola Momoh through Channels Inc Ltd. More info
Yorkshire Live an hour ago
Turn on Transparency.
Ebola outbreak is the fastest-growing with 750 dead and over 2,000 cases
Owner: Reach PLC (M&G Investment Management Ltd. & Aberforth Partners LLP 2 Largest Shareholders) More info
More

More from Africa.com

Africa.com 40 minutes ago
Turn on Transparency.
Sudan Court Sentences RSF Leader to Death
Owner: Teresa Clarke More info
Africa.com 40 minutes ago
Turn on Transparency.
French PM’s Morocco Trip Cements Diplomatic Reset
Owner: Teresa Clarke More info
Africa.com 40 minutes ago
Turn on Transparency.
Domestic Politics Drive Tanzania’s Foreign Policy
Owner: Teresa Clarke More info
More

Keep exploring Perspectify!

Create a free account and bring
more transparency to your news.

Already have an account? Log in.

Today's Media Watch

Your daily guide to the stories shaping media, journalism, and public trust.

6 hours ago
Video of Italian Prime Minister Saying Sharia law won’t be Allowed in Italy is AI-Generated
Neutral | Owner: Full Fact (Non-profit)

Learn About Our Fact-Based Transparency System

Our proprietary bias labels help you understand each outlet’s political orientation, editorial independence, and credibility based on factors like ownership, funding, affiliations, content, and media freedom. Learn more in the Perspectify FAQ.

Learn more